Q1 2022 Viridian Therapeutics Inc Earnings Call Transcript
Welcome to the Viridian Therapeutics First Quarter 2022 Conference Call. (Operator Instructions) Please note, this event is being recorded.
It is now my pleasure to introduce your host, John Jordan, Vice President of Investor Relations and Corporate Communications at Viridian. Please go ahead, sir.
Thank you, Debbie. Good afternoon, everyone, and welcome to our first quarter 2022 conference call.
Today, after the market closed, we issued a press release providing our first quarter 2022 financial results and business updates. A replay of today's call will be available on our Investor Relations section of our website approximately 1 hour after its completion. After our prepared remarks, we will open up the call for Q&A.
Before we begin, I'd like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these statements reflect our opinions only as of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |